BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30131168)

  • 1. Lessons learned in methods and analyses for pragmatic studies.
    Eckardt P; Erlanger AE
    Nurs Outlook; 2018 Sep; 66(5):446-454. PubMed ID: 30131168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Ré R; Janiaud P; Ioannidis JPA
    BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pragmatism in practice: lessons learned during screening and enrollment for a randomised controlled trial in rural northern Ethiopia.
    Molla M; Negussie H; Ngari M; Kivaya E; Njuguna P; Enqueselassie F; Berkley JA; Davey G
    BMC Med Res Methodol; 2018 Mar; 18(1):26. PubMed ID: 29514613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management.
    Meinecke AK; Welsing P; Kafatos G; Burke D; Trelle S; Kubin M; Nachbaur G; Egger M; Zuidgeest M;
    J Clin Epidemiol; 2017 Nov; 91():13-22. PubMed ID: 28716504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.
    Gaglio B; Phillips SM; Heurtin-Roberts S; Sanchez MA; Glasgow RE
    Implement Sci; 2014 Aug; 9():96. PubMed ID: 25163664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explanatory Versus Pragmatic Trials: An Essential Concept in Study Design and Interpretation.
    Merali Z; Wilson JR
    Clin Spine Surg; 2017 Nov; 30(9):404-406. PubMed ID: 29049130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms.
    Burcu M; Dreyer NA; Franklin JM; Blum MD; Critchlow CW; Perfetto EM; Zhou W
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1228-1235. PubMed ID: 32162381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements.
    Nieuwenhuis JB; Irving E; Oude Rengerink K; Lloyd E; Goetz I; Grobbee DE; Stolk P; Groenwold RH; Zuidgeest MG;
    J Clin Epidemiol; 2016 Sep; 77():95-100. PubMed ID: 27164273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.
    Irving E; van den Bor R; Welsing P; Walsh V; Alfonso-Cristancho R; Harvey C; Garman N; Grobbee DE;
    J Clin Epidemiol; 2017 Nov; 91():6-12. PubMed ID: 28502812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.
    Eichler HG; Koenig F; Arlett P; Enzmann H; Humphreys A; Pétavy F; Schwarzer-Daum B; Sepodes B; Vamvakas S; Rasi G
    Clin Pharmacol Ther; 2020 Apr; 107(4):773-779. PubMed ID: 31574163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
    Zuidgeest MGP; Goetz I; Groenwold RHH; Irving E; van Thiel GJMW; Grobbee DE;
    J Clin Epidemiol; 2017 Aug; 88():7-13. PubMed ID: 28549929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APPROACH trial: Assessing pain, patient-reported outcomes, and complementary and integrative health.
    Zeliadt SB; Coggeshall S; Thomas E; Gelman H; Taylor SL
    Clin Trials; 2020 Aug; 17(4):351-359. PubMed ID: 32522024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings.
    Glasgow RE; Estabrooks PE
    Prev Chronic Dis; 2018 Jan; 15():E02. PubMed ID: 29300695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic clinical trials at the National Institute of Nursing Research.
    Littleton-Kearney M
    Nurs Outlook; 2018 Sep; 66(5):470-472. PubMed ID: 29699773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pragmatic trials revisited: applicability is about individualization.
    Sacristán JA; Dilla T
    J Clin Epidemiol; 2018 Jul; 99():164-166. PubMed ID: 29432859
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can we assess the efficacy of psychotherapies in a clinical trial?].
    Correard N; Consoloni JL; Belzeaux R; Fakra E; Adida M; Azorin JM
    Encephale; 2016 Dec; 42(6S):S60-S64. PubMed ID: 28236995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Series: Pragmatic trials and real world evidence: Paper 5. Usual care and real life comparators.
    Zuidgeest MGP; Welsing PMJ; van Thiel GJMW; Ciaglia A; Alfonso-Cristancho R; Eckert L; Eijkemans MJC; Egger M;
    J Clin Epidemiol; 2017 Oct; 90():92-98. PubMed ID: 28694123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the design of pragmatic trials: key issues remain.
    Caro JJ; Ishak KJ
    J Comp Eff Res; 2012 Jul; 1(4):319-27. PubMed ID: 24237466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pragmatic design in randomized controlled trials.
    Purgato M; Barbui C; Stroup S; Adams C
    Psychol Med; 2015 Jan; 45(2):225-30. PubMed ID: 25065958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.